L D Karalliedde, C T Kappagoda. Show Affiliations »
Abstract
Mesh: See more » AnimalsAnti-Inflammatory Agents/therapeutic useAntioxidants/therapeutic useAortic Diseases/complicationsAortic Diseases/drug therapyAortic Diseases/metabolismAortic Diseases/pathologyAortic Rupture/etiologyAortic Rupture/metabolismAortic Rupture/pathologyAortic Rupture/prevention & controlAtherosclerosis/complicationsAtherosclerosis/drug therapyAtherosclerosis/metabolismAtherosclerosis/pathologyBiomarkers/metabolismCardiovascular Agents/chemistryCardiovascular Agents/therapeutic useComplementary TherapiesDisease ProgressionDrugs, Chinese Herbal/chemistryDrugs, Chinese Herbal/therapeutic useHumansHydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic useInflammation Mediators/metabolismLipids/bloodSimvastatin/therapeutic use
Substances: See more » Anti-Inflammatory AgentsAntioxidantsBiomarkersCardiovascular AgentsDrugs, Chinese HerbalHydroxymethylglutaryl-CoA Reductase InhibitorsInflammation MediatorsLipidstongxinluoSimvastatin
Year: 2009 PMID: 19855052 DOI: 10.1152/ajpheart.00944.2009
Source DB: PubMed Journal: Am J Physiol Heart Circ Physiol ISSN: 0363-6135 Impact factor: 4.733